Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues, net $ 4,248,182 $ 625,009
Cost of goods sold 2,759,632 1,019,991
Gross profit (loss) 1,488,550 (394,982)
Operating expenses:    
General and administration 5,909,398 3,898,089
Sales and marketing 2,430,110 1,321,149
Research and development 3,459,480 3,512,975
Total operating expenses 11,798,988 8,732,213
Operating loss (10,310,438) (9,127,195)
Other income (expense), net    
Other income (expense), net (1,162) (2,324)
Change in fair value of government grant liability (124,025) (74,392)
Interest income 200,806 97,501
Interest expense (3,867,857) (782,611)
Foreign exchange gain (loss), net (33,674) 12,937
Total other income (expense), net (3,825,912) (748,889)
Loss before income taxes (14,136,350) (9,876,084)
Provision for income taxes
Net loss (14,136,350) (9,876,084)
Less preferred dividends attributable to noncontrolling interest 390,000 334,138
Less deemed dividends attributable to accretion of redemption value 817,127 638,646
Net loss attributable to common stockholders $ (15,343,477) $ (10,848,868)
Net loss per share - basic (in Dollars per share) $ (0.15) $ (0.17)
Net loss per share - diluted (in Dollars per share) $ (0.15) $ (0.17)
Weighted average number of common shares outstanding, basic (in Shares) 105,004,818 63,035,122
Weighted average number of common shares outstanding, diluted (in Shares) 105,004,818 63,035,122